RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Compass Pathways - Stock

Compass Pathways Net Income 2024

Compass Pathways Net Income

-154.26 M USD

Ticker

CMPS

ISIN

US20451W1018

WKN

A2QCDR

In 2024, Compass Pathways's profit amounted to -154.26 M USD, a 30.22% increase from the -118.46 M USD profit recorded in the previous year.

The Compass Pathways Net Income history

YEARNET INCOME (undefined USD)
2030e1.22
2029e0.56
2028e0.07
2027e-0.1
2026e-0.16
2025e-0.15
2024e-0.15
2023-0.12
2022-0.09
2021-0.07
2020-0.06
2019-0.02
2018-0.01

Compass Pathways Aktienanalyse

What does Compass Pathways do?

Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Compass Pathways's Profit Margins

The profit margins of Compass Pathways represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Compass Pathways's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Compass Pathways's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Compass Pathways's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Compass Pathways’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Compass Pathways Stock

How much profit has Compass Pathways made this year?

Compass Pathways has made -154.26 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 30.22% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Compass Pathways publish its earnings?

Compass Pathways publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Compass Pathways?

The profits of Compass Pathways are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Compass Pathways?

You can learn more about the earnings of Compass Pathways by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Compass Pathways pay?

Over the past 12 months, Compass Pathways paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compass Pathways is expected to pay a dividend of 0 USD.

What is the dividend yield of Compass Pathways?

The current dividend yield of Compass Pathways is .

When does Compass Pathways pay dividends?

Compass Pathways pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Compass Pathways?

Compass Pathways paid dividends every year for the past 0 years.

What is the dividend of Compass Pathways?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Compass Pathways located?

Compass Pathways is assigned to the 'Health' sector.

Wann musste ich die Aktien von Compass Pathways kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Compass Pathways from 6/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Compass Pathways pay the last dividend?

The last dividend was paid out on 6/12/2024.

What was the dividend of Compass Pathways in the year 2023?

In the year 2023, Compass Pathways distributed 0 USD as dividends.

In which currency does Compass Pathways pay out the dividend?

The dividends of Compass Pathways are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Compass Pathways

Our stock analysis for Compass Pathways Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compass Pathways Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.